ArticlePLOS global public health2026
Evaluation of surveillance performance and determinants for priority vaccine-preventable diseases in Niger State, Nigeria: A CDC 2001 Guideline-based multilevel analysis.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccine-preventable diseases (VPDs) remain important causes of morbidity and mortality in sub-Saharan Africa, and evidence on subnational surveillance performance in Nigeria remains limited. We conducted a cross-sectional analytic evaluation of surveillance systems for measles, diphtheria, acute flaccid paralysis (AFP), and cerebrospinal meningitis (CSM) in Niger State, Nigeria. Data were collected from 415 clinicians, community resource persons, and surveillance focal persons across 12 purposively selected Local Government Areas using structured questionnaires adapted from CDC surveillance evaluation guidelines and aligned with IDSR guidance. Surveillance performance was assessed using sensitivity, data quality, and stability. Analyses included descriptive statistics, bivariate tests, and multivariable regression models. Reported suspected case detection was higher for measles and AFP than for CSM and diphtheria, with detection reported by 94.2% and 93.0% of respondents for measles and AFP, respectively, compared with 84.3% for CSM and 81.4% for diphtheria. Transport availability without delays was consistently associated with lower odds of surveillance failure across disease-specific models, including measles sample collection (aOR = 0.12, 95% CI: 0.05-0.28) and case confirmation (aOR = 0.07, 95% CI: 0.02-0.21), diphtheria sample collection (aOR = 0.18, 95% CI: 0.06-0.49) and confirmation (aOR = 0.22, 95% CI: 0.08-0.58), and CSM sample collection (aOR = 0.18, 95% CI: 0.06-0.54) and confirmation (aOR = 0.21, 95% CI: 0.07-0.61). Active guideline use was associated with AFP sample collection (aOR = 4.12, 95% CI: 1.72-9.87). Only 66.5% of respondents reported fully accurate submitted forms, and financial support was associated with lower odds of instability (aOR = 0.74, 95% CI: 0.56-0.97). Strengthening transport, infrastructure, financing, and data quality systems may improve VPD surveillance performance and outbreak preparedness in similar settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.